Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter March 14, 2014

Stability of glucose in plasma with different anticoagulants

  • Manfred Fobker EMAIL logo

Abstract

Background: People with hyperglycemia, especially those who are pregnant, depend on accurate blood glucose measurements for correct diagnosis of diabetes and monitoring. Glycolysis after blood draw, however, decreases glucose concentrations in blood that is collected at room temperature in the absence of a stabilizer. Cold temperatures (4°C) inhibit glycolysis; but prompt cooling and processing of each blood sample in the cold is difficult to achieve in routine clinical practice. Therefore, preservatives are used to stabilize glucose during blood collection and processing procedures that are performed at room temperature. This study examined the effect of different anticoagulants (EDTA, heparin, oxalate), with or without glycolysis inhibitors (NaF, citrate), on the stability of glucose in plasma samples – obtained from blood that was collected and stored at room temperature for up to 24 h.

Methods: Venous blood was collected from 60 volunteers; each donor blood sample was divided into six tubes, each one containing a different anti-glycolysis–anticoagulant composition. Terumo VENOSAFE Glycemia tubes contained NaF/citrate buffer)/Na2EDTA; NaF/Na-heparin; and NaF/K2oxalate. Sarstedt tubes contained NaF/citrate; NaF/Na2EDTA; and K2EDTA. At 0, 2, 8 and 24 h, plasma was obtained for glucose measurements using the Glucose Hexokinase and Glucose Oxidase methods, and the ADVIA® 1800 Clinical Chemistry System.

Results: Both methods demonstrated minimal glycolysis by 24 h (<3.8%) for the three Terumo VENOSAFE Glycemia tubes, and the Sarstedt S-Monovette GlucoEXACT tube that contained NaF/citrate. Glycolysis was higher in tubes containing NaF/Na2EDTA-alone (11.7%) and K2EDTA-alone (85%).

Conclusions: Terumo VENOSAFE Glycemia tubes (containing NaF/citrate buffer/Na2EDTA; NaF/Na-heparin; and NaF/K2oxalate) and the Sarstedt S-Monovette® GlucoEXACT tubes (containing NaF/citrate) are suitable for shipping venous whole blood samples to the testing laboratory within 24 h at room temperature.


Corresponding author: Dr. Manfred Fobker, Center of Laboratory Medicine, University Hospital of Muenster, Albert-Schweitzer-Campus 1, Building A1, 48149 Muenster, Germany, Phone: +49 2 51/8348701, Fax: +49 2 51/8347225, E-mail:

Acknowledgments

The author would like to thank the students of the MTLA school in Münster who donated blood for the experiments and E. Schneider and V. Shalhoub, PhD, Siemens Inc. for help in the preparation of the manuscript.

Conflict of interest statement

Author’s conflict of interest disclosure: The author stated that there are no conflicts of interest regarding the publication of this article. Research funding played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Research funding: This work was supported by Siemens Healthcare Diagnostics GmbH, Eschborn, Germany.

Employment or leadership: None declared.

Honorarium: None declared.

References

1. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. Br Med J 2004;328:915.10.1136/bmj.38043.583160.EESearch in Google Scholar PubMed PubMed Central

2. Hawthorne G, Irgens LM, Lie RT. Outcome of pregnancy in diabetic women in northeast England and in Norway, 1994–7. Br Med J 2000;321:730–1.10.1136/bmj.321.7263.730Search in Google Scholar PubMed PubMed Central

3. Boulot P, Chabbert-Buffet N, d’Ercole C, Floriot M, Fontaine P, Fournier A, et al. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003;26:2990–3.10.2337/diacare.26.11.2990Search in Google Scholar PubMed

4. Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 2004;27:2819–23.10.2337/diacare.27.12.2819Search in Google Scholar PubMed

5. Lauenborg J, Mathiesen E, Ovesen P, Westergaard JG, Ekbom P, Molsted-Pedersen L. Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care 2003;26:1385–9.10.2337/diacare.26.5.1385Search in Google Scholar PubMed

6. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477–86.10.1056/NEJMoa042973Search in Google Scholar PubMed

7. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339–48.10.1056/NEJMoa0902430Search in Google Scholar PubMed PubMed Central

8. American Diabetes Association Clinical Practice Recommendations 2001. Diabetes Care 2001;24(Suppl 1):S1–133.10.2337/diacare.24.1.154Search in Google Scholar PubMed

9. Metzger BE, Coustan DR. Summary and recommendations of the Fourth international workshop-conference on gestational diabetes mellitus. The organizing committee. Diabetes Care 1998;21(Suppl 2):B161–7.Search in Google Scholar

10. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002.10.1056/NEJMoa0707943Search in Google Scholar PubMed

11. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–82.10.2337/dc09-1848Search in Google Scholar PubMed PubMed Central

12. Lin YL, Smith CH, Dietzler DN. Stabilization of blood glucose by cooling with ice: an effective procedure for preservation of samples from adults and newborns. Clin Chem 1976;22:2031–3.10.1093/clinchem/22.12.2031Search in Google Scholar

13. Chan AY, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989;35:315–7.10.1093/clinchem/35.2.315Search in Google Scholar

14. Gambino R, Piscitelli J, Ackattupathil TA, Theriault JL, Andrin RD, Sanfilippo ML, et al. Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis. Clin Chem 2009;55:1019–21.10.1373/clinchem.2008.121707Search in Google Scholar PubMed

15. Mikesh LM, Bruns DE. Stabilization of glucose in blood specimens: mechanism of delay in fluoride inhibition of glycolysis. Clin Chem 2008;54:930–2.10.1373/clinchem.2007.102160Search in Google Scholar PubMed

16. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436–72.10.1093/clinchem/48.3.436Search in Google Scholar

17. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011;34:e61–99.10.2337/dc11-9998Search in Google Scholar PubMed PubMed Central

18. Waring WS, Evans LE, Kirkpatrick CT. Glycolysis inhibitors negatively bias blood glucose measurements: potential impact on the reported prevalence of diabetes mellitus. J Clin Pathol 2007;60:820–3.10.1136/jcp.2006.039925Search in Google Scholar PubMed PubMed Central

Received: 2013-12-4
Accepted: 2014-2-13
Published Online: 2014-3-14
Published in Print: 2014-7-1

©2014 by Walter de Gruyter Berlin/Boston

Downloaded on 5.3.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2013-1049/html
Scroll to top button